— Know what they know.
Not Investment Advice

VCNX OTC

Vaccinex, Inc.
1W: +4.1% 1M: +1.0% 3M: -9.8% YTD: -10.6% 1Y: +62.9% 3Y: -93.6% 5Y: -99.8%
$1.01
+0.01 (+1.00%)
 
Weekly Expected Move ±22.3%
$1 $1 $1 $1 $1
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 66 · $2.7M mcap · 1M float · 0.163% daily turnover · Short 56% of daily vol

Balance Sheet Trends

Total Assets
$3M -28.5% ▼
5Y CAGR: -10.8%
Total Liabilities
$5M -14.4% ▼
5Y CAGR: -5.9%
Shareholders Equity
-$2M -7.7% ▼
Cash & Investments
$1M -27.9% ▼
5Y CAGR: -16.8%
Total Debt
$25K -89.9% ▼
Net Debt
-$1M +16.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$11M$9M$6M$2M$1M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$11M$9M$6M$2M$1M
Net Receivables$157K$0$175K$961K$838K
Inventory$0$0$0$0$0
Other Current Assets$0$0$912K$853K$586K
Total Current Assets$11M$9M$7M$3M$3M
Property, Plant & Equip.$416K$438K$499K$282K$65K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$416K$438K$499K$282K$65K
Total Assets$12M$10M$8M$4M$3M
— Liabilities —
Accounts Payable$3M$1M$2M$2M$4M
Short-Term Debt$8M$74K$74K$75K$25K
Deferred Revenue$0$0$0$63K$0
Other Current Liabilities$2M$571K$473K$3M$0
Total Current Liabilities$13M$2M$3M$6M$5M
Long-Term Debt$1M$175K$101K$26K$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$1M$175K$247K$26K$0
Total Liabilities$14M$2M$3M$6M$5M
— Equity —
Common Stock$3K$3K$5K$0$1K
Retained Earnings-$277M-$300M-$320M-$340M-$359M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$27M$7M$5M-$2M-$2M
Total Liabilities & Equity$12M$10M$8M$4M$3M
— Key Metrics —
Total Debt$9M$390K$485K$247K$25K
Net Debt-$1M-$8M-$6M-$1M-$1M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms